These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 362064)

  • 1. [Use of "Essenciale" in the treatment of liver diseases].
    Pogromov AP; Ol'binskaia LI; Antonenko NI; Gitel' NP; Smolianitskiĭ AIa
    Klin Med (Mosk); 1978 Oct; 56(10):97-101. PubMed ID: 362064
    [No Abstract]   [Full Text] [Related]  

  • 2. [Trofopar treatment of chronic diffuse diseases of the liver].
    Loginov AS; Nikolaeva AP; Bendikov EA; Blok IuE; Sukhareva GV
    Sov Med; 1989; (7):79-81. PubMed ID: 2799537
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of chronic diseases of the liver with catergen].
    Loginov AS; Dzhalalov KD; Blok IuE; Bendikov EA; Ausheva LKh
    Ter Arkh; 1986; 58(2):73-6. PubMed ID: 3704945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A new therapy of hepatic insufficiency. Experiments with (+)-3--cyanidanol. Its importance in the treatment of alcoholic hepatitis].
    Traissac FJ; Borg R
    Minerva Dietol Gastroenterol; 1977; 23(3):237-42. PubMed ID: 372845
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experience with silymarin in the treatment of chronic liver disease(author's transl)].
    Reutter FW; Haase W
    Schweiz Rundsch Med Prax; 1975 Sep; 64(36):1145-51. PubMed ID: 1099576
    [No Abstract]   [Full Text] [Related]  

  • 6. [Silymarin in chronic liver diseases].
    Müscher CH
    Ther Ggw; 1972 Dec; 111(12):1768-70 passim. PubMed ID: 4569030
    [No Abstract]   [Full Text] [Related]  

  • 7. [The anti-steatosic effect of sulfo-adenosylmethionine (SAMe) in various forms of chronic hepatopathy. Multicentric research].
    Mazzanti R; Arcangeli A; Salvadori G; Smorlesi C; Di Perri T; Auteri A; Boggiano CA; Pippi L; Toti M; Boncompagni P; Angioli D; Caremani M; Magnolfi F; Camarri E; Motta R; Forconi A; Candidi Tommasi A; Lomi M; Soldi A
    Minerva Med; 1978 Oct; 69(48):3283-92. PubMed ID: 724140
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of ornithine carbamoyltransferase in the treatment of liver diseases].
    Caruso N; De Jacobis M; Roccato M; Sequino A; Sgoifo B; Tinello M
    Clin Ter; 1984 Jul; 110(1):37-44. PubMed ID: 6237844
    [No Abstract]   [Full Text] [Related]  

  • 9. [Is there an effective therapy for liver diseases? A multicentric clinical study].
    Stoll B; Scholz U; Haase W
    Med Welt; 1976 Apr; 27(15):707-12. PubMed ID: 772360
    [No Abstract]   [Full Text] [Related]  

  • 10. [Thiomesterone and liver function].
    Pickert H
    Med Klin; 1968 Aug; 63(31):1222-6. PubMed ID: 5719699
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical study of the effect of the administration of cathergen preparation in patients with chronic hepatic lesions].
    Maleev A; Tsvetkova V; Krŭstev Z; Kostova N; Lukanov L
    Vutr Boles; 1985; 24(5):39-43. PubMed ID: 4090451
    [No Abstract]   [Full Text] [Related]  

  • 12. [Essential choline phospholipids and their effect on HBsAg and selected biochemical tests in cirrhosis of the liver (author's transl)].
    Fassati P; Horejsí J; Fassati M; Spízek J; Jezková Z
    Cas Lek Cesk; 1981 Jan; 120(2):56-60. PubMed ID: 7471152
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of the preparation Essenciale in chronic ischemic heart disease].
    Kukes VG; Senik EA; Gneushev ET; Potekaeva SA; Milovanova NM
    Kardiologiia; 1978 Jun; 18(6):79-82. PubMed ID: 353358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical experimentation with Aïcamine in hepatic insufficiency].
    Négret JP
    Bord Med; 1972 Apr; 5(8):973-6. PubMed ID: 5053280
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experience report on Hepavis].
    Menninger U; Menninger W
    Med Welt; 1980 Oct; 31(42):1519-21. PubMed ID: 7453534
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lecithin-cholesterol-acyltransferase activity in chronic liver diseases].
    Gaskina TK; Dolgov AV; Kurilovich SA
    Vopr Med Khim; 1987; 33(4):96-9. PubMed ID: 3660750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of liver diseases, especially of fatty liver with betaine citrate].
    Semmler F
    Ther Ggw; 1977 Nov; 116(11):2113-24. PubMed ID: 337559
    [No Abstract]   [Full Text] [Related]  

  • 18. Gut-liver axis: a new point of attack to treat chronic liver damage?
    Loguercio C; De Simone T; Federico A; Terracciano F; Tuccillo C; Di Chicco M; Cartenì M
    Am J Gastroenterol; 2002 Aug; 97(8):2144-6. PubMed ID: 12190198
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of essentiale in chronic liver diseases in patients with pulmonary tuberculosis].
    Blikhar EM; Skakun NP
    Probl Tuberk; 1988; (3):41-4. PubMed ID: 3387393
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of Catergen [(+)cyanidanol-3] on some haemostatic parameters in chronic liver diseases.
    Pfliegler G; Boda Z; Dalmi L; Weisz G; Misz M; Beck P
    Ther Hung; 1984; 32(1):19-25. PubMed ID: 6571189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.